Alexa Pharmaceuticals Inc (ALXA) $0.62 -2.41%
Alexza (ALXA) is flat at 64 cents per share and 15,000 Jun 1 calls are apparently sold on the stock at an average of 12.5 cents per contract. It’s possibly closing, as the volume represents 22.2 percent of the open interest, which is 67,711 and the largest position in the name. Jun 1 calls on ALXA are 56.3 percent out-of-the-money after the 54 percent drop in the stock since October. ALXA touched a new 52-week low of 46 cents per share in late-Feb, shortly after the company priced an offering of 44 million shares. Earnings are slated for March 12 and the FDA has an NDA for the company’s ADUSAVE of May 4. (A second lot traded as I was writing, making 30,000 ALXA Jun 1 calls sold on the day).
Category: All Stocks, Pharmaceuticals & Biotechnology, Small Cap Stocks
Free Newsletter
If you enjoyed this article, sign up to receive more just like it.
About the Author (Author Profile)
Frederic Ruffy is a well-known trader, writer, and strategist who has spent years educating investors and creating intelligent, insightful, unbiased market observations that are frequently cited by the Wall Street Journal and other financial publications. As senior analyst, Fred provides frequent and regular notes and daily updates for activity of interest.
